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Preparation of brain microsomes by the calcium chloride aggregation method has been suggested 23 
as an alternative to the ultracentrifugation method. However, the effects of the calcium chloride 24 
concentration on the quality of the microsomal fractions are not known. Brain microsomes were 25 
prepared from the adult rat brains using the high-speed ultracentrifugation and low-speed calcium 26 
chloride (10-100 mM) aggregation methods (n = 5-6 per group). The microsomal protein yield 27 
(spectrometry), cytochrome P450 reductase (CPR) activity (spectrometry), and the 28 
monooxygenase activities (UPLC-MS/MS) of CYP2D and CYP2E1 were determined in the 29 
obtained fractions. Increasing the concentrations of calcium chloride progressively increased the 30 
protein yield of the low-speed microsomal fractions. However, the increased yield was associated 31 
with a significant decrease in the activities of CPR, CYP2D, and CYP2E1. Additionally, the 32 
CYP2D and CYP2E1 activities were significantly correlated with the CPR activities of the 33 
fractions. In conclusion, when an ultracentrifuge is available, preparation of brain microsomes by 34 
the ultracentrifugation method might be preferable. However, the calcium aggregation method at 35 
a calcium chloride concentration of 10 mM is an acceptable alternative to the ultracentrifuge 36 
method.      37 




The cytochrome P450 (P450) enzymes are responsible for the metabolism of most 40 
xenobiotics and endogenous compounds. In addition to the liver, which is the main organ with the 41 
highest P450 content, P450 enzymes are also expressed in extra-hepatic tissues such as the brain 42 
[1]. The distribution of P450 enzymes in different brain regions is not uniform, with the highest 43 
P450 content found in the brain stem and cerebellum, while the striatum and hippocampus 44 
reportedly contain the lowest P450 content [2]. Although the total P450 content in the brain is only 45 
0.5% - 2% of that in the liver [3, 4], brain P450 enzymes are concentrated in specific cells and 46 
important brain regions, such as the blood-brain barrier [5]. Therefore, brain P450 may 47 
significantly impact the pharmacologic activities or toxicity of the centrally-acting drugs and 48 
toxins [1, 3-5].  49 
Cytochrome P450 enzymes are primarily associated with the endoplasmic reticulum as 50 
membrane-bound enzymes, which form microsomes during the homogenization of the tissues and 51 
cell break up. Traditionally, microsomes have been prepared by ultracentrifugation of the post-52 
mitochondrial supernatant at ≥100,000 g for ≥ 1 hour. In 1971, Kamath et al. [6] reported a 53 
simplified method for the preparation of liver microsomes using aggregation of the post-54 
mitochondrial fractions by adding 8 mM calcium chloride (CaCl2), followed by a low-speed 55 
centrifugation. The method was later adapted to the preparation of brain microsomes [7-9] to 56 
improve the low yield of the relatively unstable brain microsomal proteins and preserve the 57 
enzymatic activity of the brain P450 by presumably reducing the preparation time. However, a 58 
side-by-side comparison of the two methods with regard to the effects of CaCl2 concentration on 59 
the microsomal yield and P450 monooxygenase activities is lacking in the literature. Therefore, 60 
the aim of the present study was to determine the effects of various concentrations of calcium 61 
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chloride on the microsomal protein yield and P450 activities in comparison with the 62 
ultracentrifugation method. 63 
Materials and Methods                                           64 
 65 
Chemicals 66 
Dextromethorphan (DXM), dextrorphan (DXT), DXT-d3, chlorzoxazone (CZX), 6-67 
hydroxychlorzoxazone (HCZX), and HCZX-d2 were purchased from Cerilliant (Round Rock, 68 
TX). NADPH was purchased from Sigma Aldrich (St. Louis, MO). All other reagents and 69 
chemicals were obtained from commercial sources. 70 
Preparation of Microsomes from Whole Rat Brain Using CaCl2 with Low-Speed 71 
Centrifugation 72 
The preparation of microsomes using CaCl2 was based on minor modifications of 73 
published methods [7, 8]. The modifications consisted of the addition of a low-speed (1,000 g) 74 
centrifugation of brain homogenates to remove cell debris and mitochondrial removal 75 
centrifugation speed of 10,000 g [6] instead of 17,000 g. Frozen whole brains from adult (8 to 12-76 
week old) male Sprague-Dawley rats were purchased from Innovative Research (Novi, Michigan, 77 
USA). Individual, whole brains (n = 20) were homogenized with Potter-Elvehjem homogenizer in 78 
9 volume of Tris buffer (0.1 M, pH = 7.4), containing 0.1 mM phenylmethylsulfonyl fluoride, 0.1 79 
mM dithiothreitol, 22 M butylated hydroxytoluene, 0.2 mM EDTA, 150 mM potassium chloride, 80 
and 10% (v/v) glycerol at PH 7.4 (Buffer A). The homogenate was centrifuged at 1,000 g for 15 81 
min at 4C to remove cell debris and nuclei. The supernatant was collected and centrifuged at 82 
10,000 g for 30 minutes to remove mitochondria. The mitochondrial pellet was resuspended and 83 
spun again at 10,000 g for 30 minutes, and the supernatant was collected to retrieve any trapped 84 
microsomes. The supernatants from the two 10,000 g spins were combined, and CaCl2 was added 85 
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to achieve a final concentration of 10, 25, 50, or 100 mM (n = 5 brains per concentration). After 86 
30 minutes of incubation with CaCl2 at 4
oC, the samples were centrifuged at 39,000 g for 1 hour 87 
at 4oC. The pellet was collected and resuspended in buffer A and spun again at 39,000 g for 1 hour 88 
at 4oC. The microsomal pellet was resuspended in buffer A and stored at -80°C.  89 
Preparation of Microsomes from Whole Rat Brain Using the Ultracentrifugation Method 90 
To prepare microsomes using the ultracentrifugation method (n = 6), the homogenization 91 
and the removal of cell debris and mitochondria steps were similar to the procedure outlined above 92 
for the CaCl2 method. However, instead of incubation with CaCl2, the combined post-10,000 g 93 
supernatants were spun at 110,000 g for 1 hour at 4oC. The pellet was resuspended in buffer A and 94 
spun again at 110,000 g for 1 hour at 4oC. The pellet was collected, resuspended in buffer A, and 95 
stored at -80oC. 96 
Protein Assay 97 
Microsomal protein concentrations were estimated by the Bradford method using bovine 98 
serum albumin (Thermo Scientific, Waltham, MA) as the standard. 99 
Cytochrome P450 Reductase Activity 100 
Cytochrome P450 reductase (CPR) activity was determined based on the reduction of 101 
cytochrome c by the brain microsomes using an established spectrophotometric method [10]. 102 
Dextromethorphan-O-Demethylation Activity 103 
In rats, CYP2D1-5 isoforms show significant homology and substrate overlap, including 104 
dextromethorphan-O-demethylation, with the human CYPD6 [11]. The rat brain CYP2D activity 105 
was measured based on dextrorphan (DXT) formation from dextromethorphan (DXM) at a 106 
substrate concentration of 200 µM and a reaction volume of 200 µL. Briefly, DXM in methanol 107 
was added to microcentrifuge tubes, and methanol was evaporated before adding 100 mM Tris 108 
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buffer (pH 7.4) and microsomal protein (0.2 mg/mL). The mixtures were vortex-mixed and pre-109 
incubated at 37C for 5 min. Subsequently, the reaction was started by the addition of NADPH 110 
(0.25 mM). After 30 min of incubation at 37C, the reaction was terminated by the addition of 150 111 
µl acetonitrile, containing 10 nM DXT-d3 as an internal standard. The reaction mixtures were 112 
vortex-mixed, placed on ice for 5 min, centrifuged for 5 min, and the supernatant was stored at –113 
80C before analysis by UPLC/MS/MS.  114 
Chlorzoxazone 6-Hydroxylation Activity 115 
The CYP2E1 activity was measured based on the formation of 6-hydroxychlorzoxazone 116 
(HCZX) from chlorzoxazone (CZX). Briefly, the reaction mixture (200 µL) contained 750 µM 117 
CZX and 0.4 mg/mL microsomal protein in 100 mM Tris-HCl buffer (pH 7.4). The mixtures were 118 
vortex-mixed and pre-incubated at 37C for 5 min. The reaction was then started by the addition 119 
of NADPH (0.25 mM). After 15 min of incubation at 37C, the reaction was terminated by the 120 
addition of 150 µl acetonitrile, containing 10 nM HCZX–d2 as an internal standard. The reaction 121 
mixtures were vortex-mixed, placed on ice for 5 min, centrifuged for 5 min, and the supernatant 122 
was stored at –80C before analysis by UPLC/MS/MS. 123 
UPLC-MS/MS Analysis 124 
The concentrations of DXT in the CYP2D assay and HCZX in the CYP2E1 assay were 125 
quantitated by UPLC-MS/MS (Bruker EVOQ; Billerica, MA), based on the previously reported 126 
methods [12, 13] with some modifications. Briefly, the chromatographic separation was achieved 127 
for both analytes using a Phenomenex Kinetex 1.7 μm C18 (100 A, 100 x 2.1 mm) column, 128 
connected to a Phenomenex C18 SecurityGuard ULTRA (2.1 mm) pre-column and maintained at 129 
40°C. A gradient system consisting of solvent A (5 mM ammonium formate: formic acid, 130 
100:0.05) and solvent B (acetonitrile: methanol: formic acid, 95:5:0.05), and a flow rate of 0.2 131 
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mL/min were used in both assays. For the DXT assay, the gradient conditions were 0–0.5 min, 132 
10% B; 0.5–7 min, linear gradient 10–90% B; 7–10 min, 90% B; 10 min, 10% B; 10–13 min, 10% 133 
B. For the HCZX assay, the gradient conditions were 0–0.5 min, 10% B; 0.5–4 min, linear gradient 134 
10–90% B; 4–7 min, 90% B; 7 min, 10% B; 7–9 min, 10% B. Under these conditions, the retention 135 
times were 3.2 min for DXT and 3.75 min for HCZX.  136 
The mass spectrometer ion source was operated in positive ion mode for DXT and negative 137 
ion mode for HCZX analyses. Selected reaction monitoring for the parent/fragment transitions 138 
(m/z) were 258→156.90 for DXT, 261→156.90 for DXT-d3, 184→64.2 for HCZX, and 139 
186→65.9 for HCZX-d2. Calibration standards, which were prepared in the microsomal matrix, 140 
were linear in the range of 0.25 to 50 nM for DXT or HCZX. 141 
Data Analysis 142 
The microsomal yield was estimated as the total microsomal protein obtained per each g 143 
of brain tissue. The activities of CPR, CYP2D, and CYP2D1 were expressed as per mg of the 144 
microsomal proteins (i.e., specific activity). The statistical differences between the 145 
ultracentrifugation and the calcium aggregation methods containing different concentrations of 146 
CaCl2 were analyzed by one-way ANOVA, followed by Bonferroni’s post-hoc analysis of the 147 
individual means. In all cases, a p value of < 0.05 was considered significant. Data are presented 148 
as mean ± SD. 149 
Results 150 
The protein yields and CPR activities of the microsomal fractions after the 151 
ultracentrifugation method and the 39,000 g fraction after treatment with different concentrations 152 
of CaCl2 are presented in Figure 1. Calcium aggregation method using a 10 mM concentration of 153 
CaCl2 resulted in significantly less protein yield than the ultracentrifugation method (Fig. 1A). An 154 
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increase in the concentrations of CaCl2 up to a concentration of 100 mM resulted in a progressive 155 
increase in the protein yield.  The yield at 100 mM CaCl2 (5.15 mg/g brain tissue) was 2.8 fold 156 
higher than that after the 10 mM CaCl2 concentration (1.87 mg/g brain tissue) and 1.6 fold higher 157 
than that after the ultracentrifugation method (3.14 mg/g brain tissue) (Fig. 1A). In terms of CPR 158 
activity, the CaCl2 aggregation fractions at all the tested concentrations contained significantly less 159 
CPR activity than that in the microsomal fraction obtained by the ultracentrifugation method   (Fig. 160 
1B).  161 
The CYP2D and CYP2E1 enzymatic activities of the ultracentrifugation and calcium 162 
aggregation fractions are presented in Fig. 2.  For both isoenzymes, there were no significant 163 
differences between the ultracentrifugation and the 10 mM calcium aggregation fractions in terms 164 
of their activities. However, the activities of both isoenzymes in the fractions obtained in the 165 
presence of 25–100 mM CaCl2 were significantly lower than those obtained after 166 
ultracentrifugation.  167 
The extent of correlations between CYP2D or CYP2E1 activities and the CPR activities 168 
are presented in Fig. 3. Both CYP2D (Fig. 3A) and CYP2E1 (Fig. 3B) activities were significantly 169 
(p < 0.0001) correlated with the CPR activities of the fractions. The coefficients of determination 170 
(r2) values were 0.7695 and 0.5187 for the CYP2D and CYP2E1 activities, respectively, 171 
suggesting that 77% (CYP2D) and 52% (CYP2E1) of the variations in the activities of the 172 
isoenzymes obtained by different methods and concentrations of CaCl2 are due to the changes in 173 
the CPR activities.           174 
 175 
DISCUSSION 176 
The brain contents of P450 enzymes are much lower than those in the liver [3, 4]. 177 
Additionally, it has been suggested that because of the high lipid content of the brain, brain P450 178 
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enzymes are more sensitive to lipid peroxidation and degradation during microsomal preparations 179 
[8].  Therefore, to maximize the yield of microsomal proteins obtained from the brain samples, 180 
previous studies [7-9] have suggested calcium aggregation as an alternative to ultracentrifugation. 181 
However, the effects of calcium chloride concentrations on the yield and/or the quality of the 182 
obtained fractions from the brain have not been studied. Our results presented here clearly show 183 
that although the calcium aggregation method may result in higher protein yields at higher 184 
concentrations of CaCl2 (Fig. 1A), the increase in the protein yield is associated with reduced 185 
activity of CPR (Fig. 1B) as well as the monooxygenase activities of CYP2D (Fig. 2A) and 186 
CYP2E1 (Fig. 2B).  It has been reported that calcium ions precipitate many proteins in a 187 
concentration-dependent manner [14]. Therefore, it is likely that the concentrations of CaCl2 188 
higher than 10 mM results in sedimentation of other cellular organelles and proteins, besides 189 
smooth endoplasmic reticulum.    190 
The first study reporting the calcium aggregation method for the brain microsomes [9] used 191 
8 mM of CaCl2 after a 27,000 or 15,000 g centrifugation of a 20-25% rat brain homogenate. The 192 
average protein yield for the calcium aggregation methods was similar to or higher than that for 193 
the ultracentrifugation method. However, the P450 monooxygenase activities of the microsomal 194 
fractions were not determined in that study. Additionally, the authors reported that the protein yield 195 
in the calcium aggregation method was dependent on the concentration of the original homogenate; 196 
when a 15% brain homogenate was used, the yield was 3-4 times lower than that for the 25% 197 
homogenate [9]. In our studies, the protein yield in the 10 mM CaCl2 method was 40% lower than 198 
that in the ultracentrifugation method, which might be due to the much lower concentration of 199 
brain homogenate (10%) in our studies. 200 
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Later studies by other groups indicated similar microsomal yields for both methods with 201 
either similar [7] or even higher [8] P450 enzymatic activities for the calcium aggregation method. 202 
However, these studies [7, 8] used different homogenization or storage buffers and ingredients for 203 
the ultracentrifugation and calcium aggregation methods, which might have affected the quality of 204 
the obtained fractions and the activity of the enzymes. 205 
The original calcium aggregation method applied to liver microsomes [6] presented the 206 
method's speed as one of its advantages over the traditional ultracentrifugation method. However, 207 
the length of the calcium aggregation method applied to the brain microsomes was similar to or 208 
even slightly longer than that for the ultracentrifugation method [7, 8]. Similarly, in our studies, 209 
the length of the centrifugation steps for the two methods was the same, with the calcium 210 
aggregation method requiring an extra 30 min time for incubation with Ca2Cl.    211 
In conclusion, increasing the concentrations of CaCl2 from 10 to 100 mM to prepare brain 212 
microsomes using the calcium aggregation method progressively increases the protein yield. 213 
However, the increased protein yield is associated with decreases in the CPR and monooxygenase 214 
activities of P450. Additionally, a side-by-side comparison of the calcium aggregation and the 215 
ultracentrifugation methods does not indicate any superiority for the calcium aggregation method 216 
when both the microsomal yield and monooxygenase activities are considered. Therefore, when 217 
an ultracentrifuge is available, preparation of brain microsomes by the ultracentrifugation method 218 
might be preferable. However, the calcium aggregation method at a CaCl2 concentration of 8 or 219 
10 mM is an acceptable alternative to the ultracentrifuge method.   220 
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Legends to Figures 274 
Fig. 1. Protein yield (A) and cytochrome P450 reductase (CPR) activities (B) of the brain 275 
microsomal fractions obtained by the ultracentrifugation method or calcium aggregation method 276 
using different concentrations (10-100 mM) of calcium chloride. *, p < 0.05; ***, p < 0.001; ****, 277 
p < 0.0001. 278 
Fig. 2. CYP2D (A) and CYP2E1 (B) activities of brain microsomal fractions obtained by the 279 
ultracentrifugation method or calcium aggregation method using different concentrations (10-100 280 
mM) of calcium chloride. **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.  281 
Fig. 3. The correlations between the CYP2D (A) or CYP2E1 (B) activities and cytochrome P450 282 
reductase (CPR) activities of the brain microsomal fractions obtained by the ultracentrifugation 283 
method or calcium aggregation method using different concentrations (10-100 mM) of calcium 284 
chloride.  285 



